Australia's most trusted
source of pharma news
Tuesday, 24 March 2026
Posted 24 March 2026 AM
Escalating tensions around the Strait of Hormuz could strangle supply of some of Australia's highest-volume medicines within four to six weeks, according to an industry expert.
Infios Chief Supply Chain Strategist, Steve Blough, said shortages can be expected to appear first in high-volume generic medicines, including treatments for diabetes, hypertension and cholesterol, as well as antibiotics.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.